ArticleOtolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery2026
Association of Menopause and Hormonal Contraceptive Use With Chronic Rhinosinusitis: An "All of Us" Analysis.
Article in Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveThe role of sex hormones in inflammation has attracted increased attention, but the impact of hormone-modifying states in chronic rhinosinusitis (CRS) has not been thoroughly studied. We aim to investigate the association of menopause and systemic hormonal contraceptive (SHC) use with both CRS with (CRSwNP) and without (CRSsNP) nasal polyps. STUDY
designCross-sectional analysis of data.
settingA large, national dataset of adults from the All of Us Research Program.
methodsThis study was conducted using data from 239,564 participants. CRS diagnoses, biomarker data, menopause status, and SHC use, including both estrogen-containing contraceptives (ECCs) and progestin-only contraceptives (POCs), were extracted. Multivariable logistic and linear regression models were constructed to analyze the associations of CRS diagnosis and biomarkers with menopause and SHC use.
resultsPostmenopausal participants had no significant difference in CRS odds compared to premenopausal patients (odds ratio [OR]: 1.02; 95% confidence interval [CI]: 0.94-1.11). Compared to no SHC use, POCs were not associated with CRS, but ECC use was associated with a lower odds of CRSsNP (OR: 0.71; 95% CI: 0.64-0.80) while being not associated with CRSwNP (OR: 0.82; 95% CI: 0.51-1.25). Biomarker analysis revealed that ECC use was associated with a decreased serum neutrophil concentration among participants without CRS (β: -1.29; 95% CI: -1.72 to -0.85) and among participants with CRSsNP (β: -1.66; 95% CI: -3.02 to -0.29) compared to no SHC use.
conclusionMenopause was not associated with CRS, while ECC use was associated with a lower odds of CRSsNP. Further research is needed to clarify underlying mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.